# Tradeweb Markets Inc.: financial statements, quarterly

TW · Nasdaq · CIK 1758730 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tw.md) · [Financials](/companies/tw/financials.md) · [Filings](/companies/tw/filings.md) · [Insiders](/companies/tw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [370 d](/filings/0001758730-26-000015.md) | [409](/filings/0001758730-25-000108.md) | [405](/filings/0001758730-25-000161.md) | [449](/filings/0001758730-25-000172.md) | [463 d](/filings/0001758730-26-000015.md) | [510](/filings/0001758730-26-000096.md) | [513](/filings/0001758730-26-000133.md) | [509](/filings/0001758730-26-000144.md) | [521 d](/filings/0001758730-26-000015.md) | [618](/filings/0001758730-26-000096.md) | [559](/filings/0001758730-26-000133.md) | [585](/filings/0001758730-26-000144.md) |
| Operating income | $m | [142 d](/filings/0001758730-26-000015.md) | [168](/filings/0001758730-25-000108.md) | [162](/filings/0001758730-25-000161.md) | [159](/filings/0001758730-25-000172.md) | [189 d](/filings/0001758730-26-000015.md) | [204](/filings/0001758730-26-000096.md) | [200](/filings/0001758730-26-000133.md) | [210](/filings/0001758730-26-000144.md) | [221 d](/filings/0001758730-26-000015.md) | [287](/filings/0001758730-26-000096.md) | [245](/filings/0001758730-26-000133.md) | [253](/filings/0001758730-26-000144.md) |
| Interest expense | $m | [0.7 d](/filings/0001758730-26-000015.md) | [1.7](/filings/0001758730-24-000093.md) | [0.5](/filings/0001758730-25-000161.md) | [1.4](/filings/0001758730-25-000172.md) | [0.6 d](/filings/0001758730-26-000015.md) | [0.6](/filings/0001758730-26-000096.md) | [0.4](/filings/0001758730-26-000133.md) | [0.5](/filings/0001758730-26-000144.md) | [0.4 d](/filings/0001758730-26-000015.md) | [0.6](/filings/0001758730-26-000096.md) | [0.5](/filings/0001758730-26-000133.md) | [0.5](/filings/0001758730-26-000144.md) |
| Income tax | $m | [37.6 d](/filings/0001758730-26-000015.md) | [43.6](/filings/0001758730-25-000108.md) | [47.0](/filings/0001758730-25-000161.md) | [43.5](/filings/0001758730-25-000172.md) | [50.3 d](/filings/0001758730-26-000015.md) | [53.3](/filings/0001758730-26-000096.md) | [51.5](/filings/0001758730-26-000133.md) | [59.1](/filings/0001758730-26-000144.md) | [89.6 d](/filings/0001758730-26-000015.md) | [69.8](/filings/0001758730-26-000096.md) | [63.5](/filings/0001758730-26-000133.md) | [65.1](/filings/0001758730-26-000144.md) |
| Net income | $m | [89.3 d](/filings/0001758730-26-000015.md) | [126](/filings/0001758730-25-000108.md) | [119](/filings/0001758730-25-000161.md) | [114](/filings/0001758730-25-000172.md) | [142 d](/filings/0001758730-26-000015.md) | [148](/filings/0001758730-26-000096.md) | [154](/filings/0001758730-26-000133.md) | [186](/filings/0001758730-26-000144.md) | [325 d](/filings/0001758730-26-000015.md) | [205](/filings/0001758730-26-000096.md) | [181](/filings/0001758730-26-000133.md) | [197](/filings/0001758730-26-000144.md) |
| Diluted EPS | $ per share | not reported | [0.59](/filings/0001758730-25-000108.md) | [0.55](/filings/0001758730-25-000161.md) | [0.53](/filings/0001758730-25-000172.md) | not reported | [0.69](/filings/0001758730-26-000096.md) | [0.71](/filings/0001758730-26-000133.md) | [0.86](/filings/0001758730-26-000144.md) | not reported | [0.96](/filings/0001758730-26-000096.md) | [0.85](/filings/0001758730-26-000133.md) | [0.94](/filings/0001758730-26-000144.md) |
| Basic EPS | $ per share | not reported | [0.59](/filings/0001758730-25-000108.md) | [0.56](/filings/0001758730-25-000161.md) | [0.53](/filings/0001758730-25-000172.md) | not reported | [0.70](/filings/0001758730-26-000096.md) | [0.72](/filings/0001758730-26-000133.md) | [0.87](/filings/0001758730-26-000144.md) | not reported | [0.96](/filings/0001758730-26-000096.md) | [0.85](/filings/0001758730-26-000133.md) | [0.94](/filings/0001758730-26-000144.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,706](/filings/0001758730-26-000015.md) | [1,545](/filings/0001758730-24-000093.md) | [1,718](/filings/0001758730-24-000156.md) | [1,174](/filings/0001758730-24-000190.md) | [1,340](/filings/0001758730-26-000015.md) | [1,306](/filings/0001758730-25-000108.md) | [1,630](/filings/0001758730-25-000161.md) | [1,908](/filings/0001758730-25-000172.md) | [2,085](/filings/0001758730-26-000144.md) | [1,937](/filings/0001758730-26-000096.md) | [2,058](/filings/0001758730-26-000133.md) | [2,115](/filings/0001758730-26-000144.md) |
| Total assets | $m | [7,060](/filings/0001758730-25-000038.md) | [7,396](/filings/0001758730-24-000093.md) | [7,285](/filings/0001758730-24-000156.md) | [7,337](/filings/0001758730-24-000190.md) | [7,268](/filings/0001758730-26-000015.md) | [7,370](/filings/0001758730-25-000108.md) | [8,056](/filings/0001758730-25-000161.md) | [7,996](/filings/0001758730-25-000172.md) | [8,190](/filings/0001758730-26-000144.md) | [8,296](/filings/0001758730-26-000096.md) | [8,251](/filings/0001758730-26-000133.md) | [8,429](/filings/0001758730-26-000144.md) |
| Total liabilities | $m | [1,128](/filings/0001758730-25-000038.md) | [1,320](/filings/0001758730-24-000093.md) | [1,077](/filings/0001758730-24-000156.md) | [1,050](/filings/0001758730-24-000190.md) | [869](/filings/0001758730-26-000015.md) | [823](/filings/0001758730-25-000108.md) | [1,330](/filings/0001758730-25-000161.md) | [1,061](/filings/0001758730-25-000172.md) | [1,000](/filings/0001758730-26-000144.md) | [986](/filings/0001758730-26-000096.md) | [913](/filings/0001758730-26-000133.md) | [1,095](/filings/0001758730-26-000144.md) |
| Shareholders' equity | $m | [5,374](/filings/0001758730-25-000038.md) | [5,509](/filings/0001758730-24-000093.md) | [5,631](/filings/0001758730-24-000156.md) | [5,701](/filings/0001758730-24-000190.md) | [5,800](/filings/0001758730-26-000015.md) | [5,939](/filings/0001758730-25-000108.md) | [6,098](/filings/0001758730-25-000161.md) | [6,281](/filings/0001758730-25-000172.md) | [6,508](/filings/0001758730-26-000144.md) | [6,620](/filings/0001758730-26-000096.md) | [6,635](/filings/0001758730-26-000133.md) | [6,622](/filings/0001758730-26-000144.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [245 d](/filings/0001758730-26-000015.md) | [37.9](/filings/0001758730-25-000108.md) | [286 d](/filings/0001758730-25-000161.md) | [292 d](/filings/0001758730-25-000172.md) | [282 d](/filings/0001758730-26-000015.md) | [60.2](/filings/0001758730-26-000096.md) | [409 d](/filings/0001758730-26-000133.md) | [342 d](/filings/0001758730-26-000144.md) | [356 d](/filings/0001758730-26-000015.md) | [104](/filings/0001758730-26-000096.md) | [394 d](/filings/0001758730-26-000133.md) | [347 d](/filings/0001758730-26-000144.md) |
| Capital expenditure | $m | [1.1 d](/filings/0001758730-26-000015.md) | [6.6](/filings/0001758730-25-000108.md) | [4.8 d](/filings/0001758730-25-000161.md) | [4.3 d](/filings/0001758730-25-000172.md) | [25.2 d](/filings/0001758730-26-000015.md) | [1.6](/filings/0001758730-26-000096.md) | [5.5 d](/filings/0001758730-26-000133.md) | [14.0 d](/filings/0001758730-26-000144.md) | [19.4 d](/filings/0001758730-26-000015.md) | [9.6](/filings/0001758730-26-000096.md) | [8.3 d](/filings/0001758730-26-000133.md) | [9.3 d](/filings/0001758730-26-000144.md) |
| Share repurchases | $m | [2.3 d](/filings/0001758730-26-000015.md) | [0.0](/filings/0001758730-25-000108.md) | [0.0 d](/filings/0001758730-25-000161.md) | [24.4 d](/filings/0001758730-25-000172.md) | [34.7 d](/filings/0001758730-26-000015.md) | [0.8](/filings/0001758730-26-000096.md) | [0.0 d](/filings/0001758730-26-000133.md) | [0.0 d](/filings/0001758730-26-000144.md) | [103 d](/filings/0001758730-26-000015.md) | [53.3](/filings/0001758730-26-000096.md) | [187 d](/filings/0001758730-26-000133.md) | [207 d](/filings/0001758730-26-000144.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [210](/filings/0001758730-24-000093.md) | [213](/filings/0001758730-24-000156.md) | [213](/filings/0001758730-24-000190.md) | [215](/filings/0001758730-25-000108.md) | [215](/filings/0001758730-25-000161.md) | [215](/filings/0001758730-25-000172.md) | [215](/filings/0001758730-26-000096.md) | [215](/filings/0001758730-26-000133.md) | [215](/filings/0001758730-26-000144.md) | [213](/filings/0001758730-26-000096.md) | [213](/filings/0001758730-26-000133.md) | [211](/filings/0001758730-26-000144.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:17 ET. No prices; not investment advice.
